Whitepaper: Recent advances in pharmaceutical regulations for viable environmental monitoring
Regulations provide specifications for the selection of an effective air monitoring strategy, both directly and indirectly.
With the introduction of modern manufacturing concepts and increasing number of industry standards, there is a need to adopt viable air monitoring in conjunction with the most recent regulatory trends.
Viable air monitoring is a crucial part of an environmental monitoring program in pharmaceutical manufacturing. The absence of microbial contamination is considered a critical quality attribute due to its potential to dramatically impact the safety and/or the efficacy of the drug product.
Related content from this organisation
- Active air sampler market to value $130.7 million by 2026
- On-demand webinar: Understanding and Applying USP 797
- On-demand webinar: Increasing Productivity by Leveraging Single Use Technology
- On-demand webinar: Leveraging Data Management for Root Cause Identification in Critical Environments
- On-demand webinar: Complying with USP 729, 788-1788 Regulatory Requirements